Skip to the main content

Conference paper

METABOLIC SYNDROME - THE CONSEQUENCE OF LIFELONG TREATMENT OF BIPOLAR AFFECTIVE DISORDER

Elizabeta Dadić-Hero orcid id orcid.org/0000-0002-3119-5205 ; Community Primary Health Centre, Primorsko-goranska county, Croatia, Department of Social Medicine and Epidemiology, School of Medicine, Rijeka, Croatia
Klementina Ružić orcid id orcid.org/0000-0002-4696-5102 ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Tanja Grahovac orcid id orcid.org/0000-0002-8508-6688 ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Duška Petranović ; University Hospital Center Rijeka, Internal Clinic, Rijeka, Croatia
Mirjana Graovac ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Tija Žarković Palijan ; Neuropsychiatric hospital Dr Ivan Barbot Popovaca, Croatia


Full text: english pdf 242 Kb

page 381-384

downloads: 581

cite


Abstract

Mood disturbances are characteristic and dominant feature of Mood disorders. Bipolar Affective Disorder (BAD) is a mood disorder which occurs equally in both sexes. BAD may occur in co morbidity with other mental diseases and disorders such as: Anorexia Nervosa, Bulimia Nervosa, Attention Deficit, Panic Disorder and Social Phobia. However, medical disorders (one or more) can also coexist with BAD. Metabolic syndrome is a combination of metabolic disorders that increase the risk of developing cardiovascular disease.
A 61-year old female patient has been receiving continuous and systematic psychiatric treatment for Bipolar Affective Disorder for the last 39 years. The first episode was a depressive one and it occurred after a child delivery. Seventeen years ago the patient developed diabetes (diabetes type II), and twelve years ago arterial hypertension was diagnosed. High cholesterol and triglyceride
levels as well as weight gain were objective findings. During the last nine years she has been treated for lower leg ulcer. Since metabolic syndrome includes abdominal obesity, hypertension, diabetes mellitus, increased cholesterol and serum triglyceride levels, the aforesaid patient can be diagnosed with Metabolic Syndrome. When treating Bipolar Affective Disorder, the antipsychotic drug choice should be careful and aware of its side-effects in order to avoid the development or aggravation of metabolic syndrome.

Keywords

bipolar affective disorder; metabolic syndrome

Hrčak ID:

55887

URI

https://hrcak.srce.hr/55887

Publication date:

30.6.2010.

Visits: 1.027 *